Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Dow
McKinsey
Harvard Business School
Colorcon
Moodys

Last Updated: April 9, 2020

DrugPatentWatch Database Preview

HOMAPIN-10 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Homapin-10 patents expire, and what generic alternatives are available?

Homapin-10 is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in HOMAPIN-10 is homatropine methylbromide. There are five drug master file entries for this compound. Additional details are available on the homatropine methylbromide profile page.

Summary for HOMAPIN-10
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 38
Formulation / Manufacturing:see details
DailyMed Link:HOMAPIN-10 at DailyMed
Drug patent expirations by year for HOMAPIN-10
Synonyms for HOMAPIN-10
(1R,3r,5S)-3-(2-hydroxy-2-phenylacetoxy)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-oxidanyl-2-phenyl-ethanoate bromide
2-hydroxy-2-phenylacetic acid [(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester bromide
3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate
3alpha-Hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide mandelate
8-Azoniabicyclo(3.2.1)octane, 3-((2-hydroxy-2-phenylacetyl)oxy)-8,8-dimethyl-, bromide (1:1), (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, (3-endo)-
8-Azoniabicyclo(3.2.1)octane, 3-((hydroxyphenylacetyl)oxy)-8,8-dimethyl-, bromide, endo-
8-Methylhomatropinium bromide
80-49-9
A839929
AK163175
Arkitropin
BCP13099
C16H21NO3.CH3Br
Camatropine
CCG-39581
CHEMBL1200851
CS-5716
D02070
DTXSID4023127
EINECS 201-284-0
Equipin
Equipin (TN)
Esopin
HMS1920D15
HMS2091J21
HMS3652C19
HMS500G13
Homapin
Homapin-5
Homatromide
Homatropine (methylbromide)
Homatropine DL- methylbromide
Homatropine methobromide
Homatropine methyl bromide
homatropine methylbromide
Homatropine methylbromide (USP)
Homatropine methylbromide [INN:BAN]
Homatropine methylbromide [USP:INN:BAN]
homatropine-methylbromide
HOMATROPINEMETHYLBROMIDE
Homatropini methylbromidum
Homatropini methylbromidum [INN-Latin]
HOMATROPINIUM, 8-METHYL-, BROMIDE
HY-B1388
KS-00001722
LS-75887
Malcotran
Mesopin
Methylbromure d'homatropine
Methylbromure d'homatropine [INN-French]
Methylhomatropine bromide
Methylhomatropinum bromatum
Metilbromuro de homatropina
Metilbromuro de homatropina [INN-Spanish]
MFCD00050292
N-Methylhomatropinium Bromide
Novatrin
Novatrine
Novatropine
NSC 34399
Omatropina metilbromuro [DCIT]
Q2605497
S4024
SCHEMBL20659943
Sed-Tems
Sethyl
SPECTRUM1500333
SR-05000002082
SR-05000002082-1
ST24047389
SW219039-1
Tropinium methobromide mandelate

US Patents and Regulatory Information for HOMAPIN-10

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma HOMAPIN-10 homatropine methylbromide TABLET;ORAL 086308-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
McKinsey
Harvard Business School
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.